News on Medial

9Unicorns launches Fund II with target of $200 Mn, rebrands itself to 100Unicorns

EntrackrEntrackr · 1y ago
9Unicorns launches Fund II with target of $200 Mn, rebrands itself to 100Unicorns
Medial

Early-stage accelerator fund 9Unicorns has announced the launch of its second fund following a rebranding exercise. As a result of this rebranding, 9Unicorns will now be known as 100Unicorns. 100Unicorns, a part of multistage investing firm Venture Catalysts Group, has launched its second accelerator fund called 100Unicorns Fund II with a target size of $200 million including a green-shoe option of $100 million. In its first fund, 100Unicorns Fund I (formerly 9Unicorns) had invested in several startups including Videoverse, Trunativ, ZyppElectric, Renee Cosmetics, and IGP. It provides funding ranging from $300,000 to $1 million per startup in the first round, along with product, business and fundraising support. This is followed by $500,000 to $2 million in subsequent rounds with co-investors. 100Unicorns said that it has played a crucial role in the startup ecosystem with initiatives such as DDay and ProStar serving as catalysts for over 80 startups that have collectively secured around $400 million in funding. With the new fund, the fund aims to nurture a pool of 200 outlier startups and propel them to join the billion-dollar club over the next decade.

Related News

Quadria Group launches HealthQuad Fund III with $300 Mn corpus

EntrackrEntrackr · 1m ago
Quadria Group launches HealthQuad Fund III with $300 Mn corpus
Medial

Quadria Group, a healthcare-focused private equity platform, has announced the launch of HealthQuad Fund III with a proposed raise of up to $300 million (target corpus of $200 million and a $100 million greenshoe option). As the successor to Funds I and II, the third fund aims to build on a proven track record of identifying and scaling pioneering healthcare ventures that have significantly expanded access, affordability, and quality of care across India. The launch aligns with Quadria’s long-term vision of creating India’s most integrated healthcare investment platform, offering capital solutions from early-stage innovation to scaled growth across the healthcare value chain. Launched in 2016, HealthQuad was initiated as a distinct investment vehicle focused on supporting disruptive, tech-enabled healthcare models at the early-growth stage. Funds I and II backed over 18 companies, including Qure.ai, Medikabazaar, THB, Wysa, Ekincare, Redcliffe Labs, GoApptiv, and Strand Life Sciences. With Fund III, Quadria takes a step toward establishing a broader healthcare investment franchise. Dr. Amit Varma, Abrar Mir, and Sunil Thakur will assume full ownership and control of the platform following its separation from KOIS. A significant portion of the existing investment and committee team will remain involved in managing current portfolio investments. Quadria intends to leverage its global and domestic institutional investor network to support the fund and create scaled impact. The firm recently closed Quadria Capital Fund III at $1.07 billion, backed by leading global institutions. Founded in 2012, Quadria Capital manages over $4 billion in assets across 27 investments in South and Southeast Asia, including India, Vietnam, Indonesia, Malaysia, and Singapore. The firm aims to generate sustainable value by partnering with high-impact healthcare businesses and delivering strong investor returns.

HealthKois launches $300 Mn healthcare transformation fund

EntrackrEntrackr · 1m ago
HealthKois launches $300 Mn healthcare transformation fund
Medial

HealthKois launches $300 Mn healthcare transformation fund Healthcare-focused investment firm HealthKois has launched with a target corpus of $300 million, along with a $100 million green shoe option. Spearheaded by the founding team behind HealthQuad — Charles Janssen (Managing Partner), Ajay Mahipal (Partner), and Dr. Pinak Shrikhande (Partner) — HealthKois will back early growth-stage healthcare companies across healthtech, life sciences, medtech, healthcare delivery, and climate health. The fund plans to invest between $7 million to $25 million per company over the next four years, focusing on businesses with proven clinical outcomes, scalable operations, and sustainable infrastructure models. “HealthKois will support healthcare enterprises addressing gaps in access, affordability, and quality,” said Charles Janssen. “With access to over 75% proprietary deal flow, we are positioned to deliver both financial returns and real-world health impact.” HealthKois will adopt a hands-on, founder-first approach, offering capital alongside strategic guidance, market expansion support, and governance planning. The firm’s team brings over 100 years of combined experience in clinical care, operations, and healthcare investing, and operates across Asia and Europe. HealthKois builds on the success of HealthQuad Funds I and II, which claims to have impacted over 90 million lives and serve more than 8 million patients annually.

Download the medial app to read full posts, comements and news.